Enzolytics (Enzolytics) Market Cap : $16.90 Mil (As of May. 01, 2024)

View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Enzolytics's share price for the quarter that ended in Jun. 2011 was $55. Enzolytics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2011 was 0.06 Mil. Therefore, Enzolytics's market cap for the quarter that ended in Jun. 2011 was $3.26 Mil.

Enzolytics's quarterly market cap declined from Dec. 2010 ($7.96 Mil) to Mar. 2011 ($4.08 Mil) and declined from Mar. 2011 ($4.08 Mil) to Jun. 2011 ($3.26 Mil).

Enzolytics's annual market cap increased from Jul. 2008 ($0.00 Mil) to Dec. 2009 ($3.86 Mil) and increased from Dec. 2009 ($3.86 Mil) to Dec. 2010 ($7.96 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Enzolytics's Enterprise Value for Today is $15.75 Mil.

Enzolytics Market Cap Historical Data

The historical data trend for Enzolytics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics Market Cap Chart

Enzolytics Annual Data

Trend

Dec07

Jul08

Dec09

Dec10

Market Cap

3.86

7.96

Enzolytics Quarterly Data
	Sep07	Dec07	Apr08	Jul08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Market Cap	Get a 7-Day Free Trial										1.40	3.32	7.96	4.08	3.26

Competitive Comparison of Enzolytics's Market Cap

For the Biotechnology subindustry, Enzolytics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Enzolytics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Enzolytics's Market Cap distribution charts can be found below:

* The bar in red indicates where Enzolytics's Market Cap falls into.

Enzolytics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Enzolytics's Market Cap for the fiscal year that ended in Dec. 2010 is calculated as

Market Cap (A: Dec. 2010 )	=	Share Price (A: Dec. 2010 )	*	Shares Outstanding (EOP) (A: Dec. 2010 )
	=	$155	*	0.05138
	=	$7.96

Enzolytics's Market Cap for the quarter that ended in Jun. 2011 is calculated as

Market Cap (Q: Jun. 2011 )	=	Share Price (Q: Jun. 2011 )	*	Shares Outstanding (EOP) (Q: Jun. 2011 )
	=	$55	*	0.0592
	=	$3.26

Enzolytics (OTCPK:ENZC) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Enzolytics Market Cap Related Terms

Thank you for viewing the detailed overview of Enzolytics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzolytics (Enzolytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Market Cap

Traded in Other Exchanges

N/A

Address

1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013

Website

https://www.enzolytics.com

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.